Status:
UNKNOWN
Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight
Lead Sponsor:
University of Turku
Collaborating Sponsors:
Academy of Finland
Conditions:
Allergic Disease
Obesity
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Combined programme: Nutrition, Allergy, Mucosal immunology and Intestinal microbiota (NAMI) was created with the objective to reverse the rising trend of chronic inflammatory diseases, such as allergi...
Detailed Description
While allergic diseases comprise the most common chronic disease in childhood, obesity is the most prevalent nutritional disorder among children throughout the world. In Europe, an estimated 20% of ch...
Eligibility Criteria
Inclusion
- Pregnant women from families with at least one family member having an allergic disease
Exclusion
- Women presenting severe immunological or other chronic diseases (rheumatoid arthritis, diabetes, inflammatory bowel disease, thyroid diseases, malignancies etc.)
- Women who cannot be expected to comply with treatment
- Women currently participating or having participated in other clinical trial during the last 2 months prior to the beginning of the intervention.
Key Trial Info
Start Date :
February 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00167700
Start Date
February 1 1997
End Date
December 1 2015
Last Update
October 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Central Hospital
Turku, Finland, 20520